<DOC>
	<DOC>NCT00399906</DOC>
	<brief_summary>The purpose of this clinical research study is to learn if BMS-582949 alone is an effective treatment for moderate to severe psoriasis. The safety of the drug and the effectiveness of each dose will also be studied.</brief_summary>
	<brief_title>A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Males and Females (not nursing or not pregnant) 1875 years of age Diagnosis of moderate to severe psoriasis for at least six months at the time of screening Subjects will require washout of certain therapies for the treatment of psoriasis but will be allowed to continue on certain topical therapies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>